Subclinical thyroid disease

Mayo Clinic Proceedings

Volumn 76, Issue 4, 2001, Pages 413-417

  Fatourechi, Vahab ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

AGED; BONE DISEASE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HASHIMOTO DISEASE; HEART DISEASE; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMAGING; PHYSICAL EXAMINATION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; THYROID ADENOMA; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROID NODULE; TUMOR VOLUME;

EID: 0035088235     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.4.413     Document Type: Short Survey

References (26)

1. Klee GG, Hay ID, Biochemical testing of thyroid function. Endocrinol Metab Clin North Am. 1997;26:763-775.
2. Hay ID, Klee GG, Thyroid dysfunction. Endocrinol Metab Clin North Am. 1988; 17:473-509.
3. Burguera B, Gharib H, Thyroid incidentalomas: prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am. 2000;29:187-203.
4. Tan GH, Gharib H, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997; 126:226-231.
5. Smallridge RC, Disclosing subclinical thyroid disease: an approach to mild laboratory abnormalities and vague or absent symptoms. Postgrad Med. January 2000;107:143-146, 149-152.
6. Schneider DL, Barrett-Connor EL, Morton DJ, Thyroid hormone use and bone mineral density in elderly women: effects of estrogen. JAMA. 1994;271:1245-1249.
7. Samuels MH, Subclinical thyroid disease in the elderly. Thyroid. 1998;8:803-813.
8. Sawin CT, Geller A, Wolf PA, et al, Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N EnglJMed. 1994;331:1249-1252.
9. Biondi B, Fazio S, Carella C, et al, Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1993;77:334-338.
10. Subclinical hyperthyroidism: position statement from the American Association of Clinical Endocrinologists, Endocr Pract. 1999; 5:220-221.
11. Kabadi UM, "Subclinical hypothyroidism": natural course of the syndrome during a prolonged follow-up study. Arch Intern Med. 1993:153:957-961.
12. Fatourechi V, Demystifying autoimmune thyroid disease: which disorders require treatment? Postgrad Med. January 2000; 107:127-134.
13. Vanderpump MP, Tunbridge WM, French JM, et al, The incidence of thyroid disorders in the community: a twenty-year follow-
14. up of the Whickham Survey, Clin Endocrinol (Oxf). 1995;43:5568.
15. Danese MD, Powe NR, Sawin CT, Ladenson PW, Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996;276:285-292.
16. Ladenson PW, Singer PA, Ain KB, et al, American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000; 160:1573-1575.
17. Helfand M, Redfern CC, American College of Physicians, Clinical guideline, part 2: screening for thyroid disease: an update [published correction appears in Ann Intern Med. 1999; 130:246]. Ann Intern Med. 1998;129:144-158.
18. Glinoer D, Delange F, The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid. 2000; 10:871-887.
19. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC, Lthyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med. 1984; 101:18-24.
20. Jaeschke R, Guyatt G, Gerstein H, et al, Does treatment with Lthyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med. 1996;1 1:744-749.
21. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg P-A, Lindstedt G, A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf). 1988;29:63-76.
22. Kong WM, Sheikh M, Lumb P, et al, A randomised controlled trial of thyroxine treatment in mild subclinical hypothyroidism [abstract]. Endocr Soc Annu Meet Program Abstr. 2000;82:597. Abstract 2466.
23. Kahaly GJ, Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000; 10:665-679.
24. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000; 132:270-278.
25. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC, The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160:526-534.
26. Biondi B, Fazio S, Palmieri EA, et al, Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999;84:2064-2067.